Roquette Showcases Its Expanded Consumer Healthcare Capabilities at Vitafoods Europe 2026

LILLE, France--(BUSINESS WIRE)--Apr 28, 2026--

Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will present its expanded portfolio at Vitafoods Europe 2026 which is taking place from May 5 to May 7 in Barcelona. Roquette’s offering is designed to help consumer healthcare brands stay future‑ready and accelerate consumer-centric innovations for everyday well-being.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428405433/en/

As consumer expectations rise and shelf competition intensifies, dietary supplement and over-the-counter (OTC) brands, as well as contract development and manufacturing organizations (CDMOs), face growing pressure to deliver clean-label products that combine efficacy, strong sensory experiences, regulatory confidence, and speed to market. At Vitafoods Europe 2026, Roquette will demonstrate its role as a versatile partner, supporting customers from early concept to commercial launch across multiple dosage formats such as hard and softgel capsules, gummies, (mini) tablets, and chewables.

Where plant-based power meets high-end performance for diverse dietary requirements

“Roquette’s consumer healthcare business is built on a strong legacy of trusted and innovative ingredient brands,” said Laura Owens, Global Consumer Healthcare Marketing Leader for Roquette’s Health and Pharma Solutions Business Unit. “We are here to support supplement brands and CDMOs with solutions designed for today’s fastest growing consumer health needs such as GLP-1 related solutions, stress relief, or sustained sleep.”

Roquette’s broadened consumer healthcare portfolio and expertise has expanded after acquisitions to include Qualicaps hard capsules and former IFF Pharma Solutions brands such as SeaGel® carrageenan‑based softgel technology and VERDIGEL™ pectin premium for gummies. It offers everything needed to ensure supplement and OTC products are ready to meet diverse dietary requirements such as vegan, halal or kosher. Across formats, Roquette enables brands to deliver products that align with consumers’ well-being and health routines as well as clean-label expectations, ultimately building long-term value and trust.

What visitors will experience at the Roquette booth 3F112

In hall 3, booth 3F112, visitors will discover a broad range of formulation solutions designed for modern consumer healthcare applications including the following highlights:

To complete key aspects of the formulation cycle, visitors can also explore ReadiLYCOAT® film coating systems and HPMC/MCC nutraceutical and excipient systems designed for immediate or controlled release performance.

Why Roquette?

By partnering with Roquette, consumer healthcare brands and contract manufacturers benefit from:

Meet Roquette at Vitafoods Europe 2026:

May 5–7, at Fira Barcelona Gran Via, Barcelona, Spain
Hall 3, Booth 3F112

About Roquette

Roquette is a global leader in sustainable plant-based solutions, driving innovation and strong partnerships that are shaping the future of nutrition, health, and bioindustry.

The company harnesses natural resources such as wheat, corn, seaweed, and cellulose to craft high-performance ingredients used in everyday foods, oral medications, advanced biopharmaceuticals, and a range of bio-based products.

A family-owned company with over 90 years of expertise and 11,000 employees, Roquette serves clients in over 150 countries and is committed to creating lasting value for customers, patients, consumers, and society.

Together, we turn the potential of nature into the essentials of life.

Discover more about Roquette here.

Credits to Roquette

TOKYO (AP) — Shares retreated in Asia and oil prices gained on Tuesday as diplomatic efforts to end the Iran war once again appeared to stall.

Despite a tenuous ceasefire, the Strait of Hormuz remains effectively closed. Much of Asia, including resource-poor Japan, relies on that route for its oil shipments.

Japan's benchmark Nikkei 225 fell 1% to 59,917.46 after the central bank opted to keep its key interest rate unchanged at 0.75%.

The Bank of Japan said that while the economy was still growing moderately it was expected to slow as the war pushes for crude oil and other products higher. The vote by its monetary policy board at 6-3 was not unanimous. Pressures have been growing for Japan to gradually raise interest rates after keeping them near or below zero for years to combat deflation.

“There are various risks to the outlook," it said in a statement. “For the time being it is necessary to pay particular attention to the impact of the future course of the situation in the Middle East.”

Elsewhere in Asia, South Korea's Kospi edged up 0.4% to 6,641.02.

Hong Kong's Hang Seng dipped 1.1% to 25,642.69, while the Shanghai Composite shed 0.3% to 4,074.47.

Australia’s S&P/ASX 200 lost 0.6% to 8,710.70.

The price for a barrel of Brent crude to be delivered in June climbed $1.85 to $110.08. Brent to be delivered in July, which is where more of the trading is happening in the oil market, rose $2 to $103.69 per barrel.

Brent prices were at about $70 per barrel before the war and have briefly shot to nearly $120. Benchmark U.S. crude added $1.43 to $97.80 a barrel.

The U.S. Federal Reserve, European Central Bank, and Bank of England will also be announcing interest-rate decisions this week.

On Monday, the S&P 500 inched 0.1% higher to its latest all-time high, at 7,137.91, a downshift following weeks of big gains driven by strong corporate profit reports and hopes that the economy can avoid a worst-case scenario despite the war.

The Dow Jones Industrial Average dipped 0.1% to 49,167.79. The Nasdaq composite index edged 0.2% higher.

Investors are also looking ahead to earnings reports from some of Wall Street’s most influential stocks, including Alphabet, Amazon, Meta Platforms, Microsoft and Apple.

In the bond market, Treasury yields ticked higher following the rise in oil prices. The yield on the 10-year Treasury note rose to 4.33% from 4.31% late Friday.

In currency trading early Tuesday, the U.S. dollar inched down to 159.04 Japanese yen from 159.42 yen. The euro cost $1.1702, down from $1.1720.

Yuri Kageyama is on Threads: https://www.threads.com/@yurikageyama

People past an electronic stock board showing Japan's Nikkei index at a securities firm Tuesday, April 28, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board chart showing Japan's Nikkei index at a securities firm, Tuesday, April 28, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person looks at an electronic stock board showing Japan's Nikkei index at a securities firm, Tuesday, April 28, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm Tuesday, April 28, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)

A person walks in front of an electronic stock board showing Japan's Nikkei index at a securities firm, Tuesday, April 28, 2026, in Tokyo. (AP Photo/Eugene Hoshiko)